NanoR: A user-friendly R package to analyze and compare nanopore sequencing data

Por Bolognini, Davide, Bartalucci, Niccolò, Mingrino, Alessandra, Vannucchi, Alessandro Maria, Magi, Alberto
Publicado no PLoS One (2019)

mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms

Por Bogani, Costanza, Bartalucci, Niccolò, Martinelli, Serena, Tozzi, Lorenzo, Guglielmelli, Paola, Bosi, Alberto, Vannucchi, Alessandro M.
Publicado em 2013

Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms

Por Bartalucci, Niccolò, Tozzi, Lorenzo, Bogani, Costanza, Martinelli, Serena, Rotunno, Giada, Villeval, Jean-Luc, Vannucchi, Alessandro M
Publicado em 2013

The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera

Por Pieri, Lisa, Bogani, Costanza, Guglielmelli, Paola, Zingariello, Maria, Rana, Rosa Alba, Bartalucci, Niccolò, Bosi, Alberto, Vannucchi, Alessandro M.
Publicado em 2009

Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/CIP2A axis

Por Bartalucci, Niccolò, Calabresi, Laura, Balliu, Manjola, Martinelli, Serena, Rossi, Maria Caterina, Villeval, Jean Luc, Annunziato, Francesco, Guglielmelli, Paola, Vannucchi, Alessandro M.
Publicado no Oncotarget (2017)

Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia

Por Antonioli, Elisabetta, Carobbio, Alessandra, Pieri, Lisa, Pancrazzi, Alessandro, Guglielmelli, Paola, Delaini, Federica, Ponziani, Vanessa, Bartalucci, Niccolò, Tozzi, Lorenzo, Bosi, Alberto, Rambaldi, Alessandro, Barbui, Tiziano, Vannucchi, Alessandro M.
Publicado em 2010

Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea

Por Pacilli, Annalisa, Rotunno, Giada, Mannarelli, Carmela, Fanelli, Tiziana, Pancrazzi, Alessandro, Contini, Elisa, Mannelli, Francesco, Gesullo, Francesca, Bartalucci, Niccolò, Fattori, Giuditta Corbizi, Paoli, Chiara, Vannucchi, Alessandro M., Guglielmelli, Paola
Publicado no Blood Cancer J (2018)

RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features

Por Coltro, Giacomo, Rotunno, Giada, Mannelli, Lara, Mannarelli, Carmela, Fiaccabrino, Sara, Romagnoli, Simone, Bartalucci, Niccolò, Ravenda, Enrica, Gelli, Eleonora, Sant’Antonio, Emanuela, Patnaik, Mrinal M., Tefferi, Ayalew, Vannucchi, Alessandro M., Guglielmelli, Paola
Publicado no Blood Adv (2020)

Role of TGF‐β1/miR‐382‐5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis

Por Rossi, Chiara, Zini, Roberta, Rontauroli, Sebastiano, Ruberti, Samantha, Prudente, Zelia, Barbieri, Greta, Bianchi, Elisa, Salati, Simona, Genovese, Elena, Bartalucci, Niccolò, Guglielmelli, Paola, Tagliafico, Enrico, Rosti, Vittorio, Barosi, Giovanni, Vannucchi, Alessandro M., Manfredini, Rossella
Publicado no Mol Oncol (2018)

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis

Por Tefferi, Ayalew, Guglielmelli, Paola, Nicolosi, Maura, Mannelli, Francesco, Mudireddy, Mythri, Bartalucci, Niccolo, Finke, Christy M., Lasho, Terra L., Hanson, Curtis A., Ketterling, Rhett P., Begna, Kebede H., Naseema Gangat, Pardanani, Animesh, Vannucchi, Alessandro M.
Publicado no Leukemia (2018)

Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants

Por Salati, Simona, Genovese, Elena, Carretta, Chiara, Zini, Roberta, Bartalucci, Niccolò, Prudente, Zelia, Pennucci, Valentina, Ruberti, Samantha, Rossi, Chiara, Rontauroli, Sebastiano, Enzo, Elena, Calabresi, Laura, Balliu, Manjola, Mannarelli, Carmela, Bianchi, Elisa, Guglielmelli, Paola, Tagliafico, Enrico, Vannucchi, Alessandro M., Manfredini, Rossella
Publicado no Sci Rep (2019)

Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis

Por Guglielmelli, Paola, Barosi, Giovanni, Rambaldi, Alessandro, Marchioli, Roberto, Masciulli, Arianna, Tozzi, Lorenzo, Biamonte, Flavia, Bartalucci, Niccolò, Gattoni, Elisabetta, Lupo, Maria Letizia, Finazzi, Guido, Pancrazzi, Alessandro, Antonioli, Elisabetta, Susini, Maria Chiara, Pieri, Lisa, Malevolti, Elisa, Usala, Emilio, Occhini, Ubaldo, Grossi, Alberto, Caglio, Silvia, Paratore, Simona, Bosi, Alberto, Barbui, Tiziano, Vannucchi, Alessandro M.
Publicado em 2011